MedTech Spectrum

Article Name China

PHASE Scientific Launches World’s Largest Clinical Study on Urine-Based Cervical Cancer Screening in China

The 17,000-woman study, led by Peking University Shenzhen Hospital, sets three world records and integrates PHASiFY™ DNA concentration technology with AI-powered diagnostics to advance scalable, non-invasive screening in line with WHO’s 2030 elimination goals.

23rd September, 2025

PHASE Scientific Launches Urine-Based Cervical Cancer (HPV) Screening Clinical Study

The study applies PHASE Scientific’s proprietary PHASiFY urine-based DNA concentration technology

22nd September, 2025

China’s Healthcare Investment Climate: Rebalancing Global and Local Innovation

Yang Huang, Head of China Healthcare Research at J.P. Morgan, unpacks how favourable policies, demographic shifts, and global collaborations are shaping the future of biopharma and medtech investment in China.

19th September, 2025

Fangzhou Unveils XingShi LLM to Advance AI-Driven Chronic Disease Management

XS LLM integrates multimodal capabilities, image and speech recognition, natural language processing, large-scale medical knowledge storage, and reasoning

15th September, 2025

Fangzhou Secures 2nd National Science Foundation Project Approval

The study will examine the influence of human-AI collaboration models on consumer adoption

03rd September, 2025

Hua Medicine Strengthens Financial Position to Support Sustainable Growth

One-Time Income Release and Improved Gross Margins Strengthen Financials

01st September, 2025

Yunkang Group's 2025 Interim Net Loss Narrows, Demonstrating Strong Operational Resilience

AI Empowers Medical Institution Alliances to Strengthen New Quality Productive Forces

01st September, 2025

Fosun Unlocks Adaptive Growth Through Pharma Innovation and Globalisation

In the first half of 2025, Fosun’s four core subsidiaries generated a total revenue of RMB63.61 billion

01st September, 2025

Essex Bio-Technology Drives Growth and Innovation

Revenue up 5.8 per cent to HK$876.5 million, Profit up 3.8 per cent to HK$163.4 million

01st September, 2025

Neusoft Medical Systems Launches China's First Photon-Counting CT with NMPA Approval

Photon-counting CT (PCCT) is considered a breakthrough in next-generation imaging

28th August, 2025

Foxconn Technology invests $30Mn in Robocore to expand into Medical and Elderly Care Robotics Market

Projects 5X Revenue Growth by 2028, Accelerates Global Market Leadership and Paves the Way for IPO

20th August, 2025

NMPA accepted Essex biologics license application for EB12 20145P HLX04 O for wet age related macular degeneration

Phase 3 AURA 1 trial meets primary endpoint paving way for new treatment option in China

15th August, 2025

Bracco Imaging’s SonoVue® Secures NMPA Approval for HyCoSy Use in China, Enhancing Non-Invasive Infertility Diagnostics

Regulatory milestone supports China’s reproductive health goals by enabling radiation-free, high-accuracy ultrasound imaging to assess fallopian tube patency and uterine abnormalities in women.

06th August, 2025

2025–2032 China Neuro-Intervention Market Insights and Strategic Outlook

In-Depth Market Analysis Featuring Key Players Including Peijia Medical, HeMo Bioengineering, MicroPort NeuroTech, Zylox-Tonbridge, and Others – ResearchAndMarkets.com

11th July, 2025